DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC™) for the Treatment of FSHD
2021 AAN Annual Meeting
Optimization of AOC 1001, an antibody-oligonucleotide conjugate targeting the underlying cause of myotonic dystrophy type 1
2021 FSHD Society IRC Annual Meeting
DUX4 siRNA Optimization for the Development of an Antibody Oligonucleotide Conjugate (AOC™) for the Treatment of FSHD